Bioprocessing

M13 Bacteriophage Nanovaccine – Review
Research & Development M13 Bacteriophage Nanovaccine – Review

Biological engineers have spent decades searching for a nanoscale Swiss Army knife that can simultaneously alert the immune system and deliver precision-guided payloads to malignant cells without the systemic toxicity typically associated with traditional chemotherapy. The M13 bacteriophage, a

How Are Takara Bio and SPT Labtech Automating NGS Workflows?
Tech & Innovation How Are Takara Bio and SPT Labtech Automating NGS Workflows?

University of Cambridge experts verified that the integrated Takara Bio and SPT Labtech system delivers the precision required for complex stratified medicine research projects. This collaboration represents a pivotal shift in the landscape of next-generation sequencing (NGS) by merging Takara

Human Amniotic Membrane Advances in Regenerative Medicine
Research & Development Human Amniotic Membrane Advances in Regenerative Medicine

Injectable amniotic membrane powder is being investigated for its disease-modifying potential in treating osteoarthritis, as it contains factors that suppress enzymes responsible for cartilage breakdown. This transition from a specialized tool in ophthalmology to a cornerstone of orthopedics and

Model-Guided Optimization Boosts Protein Production in Yeast
Biotech & Bioprocessing Model-Guided Optimization Boosts Protein Production in Yeast

Faster-growing yeast cells in continuous culture produce enzymes with higher specific activity, suggesting that growth rate directly influences the quality of the final protein product. This discovery marks a pivotal shift in how bioengineers approach the metabolic trade-off between cellular growth

SÜDPACK Medica Launches Recyclable Mono-PE Barrier System
Management & Regulatory SÜDPACK Medica Launches Recyclable Mono-PE Barrier System

Manufacturing packaging in ISO Class 7 clean rooms ensures that the stringent requirements for cytotoxicity and purity in pharmaceutical applications are met. This baseline of safety is becoming even more critical as the life sciences industry shifts toward high-purity bioprocessing workflows that

Brepocitinib’s Uveitis Results Put Care Workflows in Focus
Biotech & Bioprocessing Brepocitinib’s Uveitis Results Put Care Workflows in Focus

Twelve weeks was the median time to treatment failure among placebo recipients in Priovant Therapeutics’ two Phase 3 uveitis trials. For healthcare managers, that result brings the operating challenge into focus: maintaining control of an eye condition that can cause blindness while managing the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later